Send me a link:

*Text messaging rates may apply.

 Dow Up0.36% Nasdaq Up0.71%

Biogen Idec Inc. (BIIB)

-NasdaqGS
303.67 1.17(0.39%) Jul 22, 4:00PM EDT
|Pre-Market : 324.00 Up 20.33 (6.69%) 8:00AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 6,932,199   5,516,461   5,048,634  
Cost of Revenue857,726  545,494  466,780  
Gross Profit 6,074,473   4,970,967   4,581,854  
Operating Expenses
Research Development1,444,053  1,334,919  1,219,602  
Selling General and Administrative1,796,861  1,622,562  1,409,969  
Non Recurring -  2,225  19,026  
Others342,948  202,204  208,566  
Total Operating Expenses -  3,161,910  2,857,163  
Operating Income or Loss 2,515,509   1,855,849   1,724,691  
Income from Continuing Operations
Total Other Income/Expenses Net(10,032)46,048  (13,477)
Earnings Before Interest And Taxes2,505,477  1,901,897  1,711,214  
Interest Expense -   -   -  
Income Before Tax2,505,477  1,901,897  1,711,214  
Income Tax Expense601,014  470,554  444,528  
Minority Interest -   -  (32,258)
Net Income From Continuing Ops1,887,239  1,426,825  1,234,428  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 1,862,341   1,380,033   1,234,428  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 1,862,341   1,380,033   1,234,428  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.